Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CART-immune-related adverse events after BCMA CAR-T therapy.

Molecular therapy. Oncology·2026
Same author

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

Blood advances·2026
Same author

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

American journal of hematology·2026
Same author

Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System Involvement.

Blood advances·2026
Same author

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Mutational Profiling Links Biologically Relevant Variants to Multi-Systemic Rosai-Dorfman Disease.

Blood advances·2026

Related Experiment Video

Updated: May 2, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.0K

Extramedullary Multiple Myeloma: Challenges and Opportunities.

Matthew Ho1, Luca Paruzzo1, Janna Minehart1

  • 1Division of Hematology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Current Oncology (Toronto, Ont.)
|March 26, 2025
PubMed
Summary

Extramedullary multiple myeloma (EMM) involves cancer cells spreading outside the bone marrow, leading to aggressive disease. Understanding EMM biology and microenvironment is crucial for developing targeted therapies.

Keywords:
CAR-TMAPKbispecific antibodiesparaskeletal diseaserelapsed myeloma

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.7K

Related Experiment Videos

Last Updated: May 2, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.7K

Area of Science:

  • Hematology
  • Oncology
  • Cancer Biology

Background:

  • Extramedullary multiple myeloma (EMM) is characterized by myeloma cells proliferating outside the bone marrow.
  • EMM is associated with aggressive disease, high-risk cytogenetics, and early relapse.
  • It independently predicts shorter progression-free and overall survival, even with advanced immunotherapies.

Purpose of the Study:

  • To review the current understanding of EMM biology.
  • To highlight the distinct molecular and microenvironmental characteristics of EMM compared to standard multiple myeloma.
  • To discuss current treatment strategies for EMM.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Focuses on molecular and microenvironmental factors driving EMM dissemination.
  • Examines current therapeutic approaches for EMM.

Main Results:

  • EMM cells possess unique abilities to proliferate in extramedullary sites.
  • EMM biology is distinct from intra-osseous multiple myeloma.
  • Current treatment strategies are reviewed, noting a lack of large-scale, EMM-specific studies.

Conclusions:

  • EMM represents an aggressive subtype of multiple myeloma with unique biological features.
  • Further research into EMM's molecular and microenvironmental drivers is needed.
  • Development of targeted therapies and EMM-specific clinical trials is warranted.